DK1233788T3 - Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan - Google Patents

Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan

Info

Publication number
DK1233788T3
DK1233788T3 DK00981627T DK00981627T DK1233788T3 DK 1233788 T3 DK1233788 T3 DK 1233788T3 DK 00981627 T DK00981627 T DK 00981627T DK 00981627 T DK00981627 T DK 00981627T DK 1233788 T3 DK1233788 T3 DK 1233788T3
Authority
DK
Denmark
Prior art keywords
carnitine
chitosan
prevention
treatment
disorders due
Prior art date
Application number
DK00981627T
Other languages
Danish (da)
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of DK1233788T3 publication Critical patent/DK1233788T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
DK00981627T 1999-11-18 2000-11-14 Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan DK1233788T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000707A IT1307278B1 (it) 1999-11-18 1999-11-18 Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
PCT/IT2000/000462 WO2001035944A2 (en) 1999-11-18 2000-11-14 Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan

Publications (1)

Publication Number Publication Date
DK1233788T3 true DK1233788T3 (da) 2003-09-01

Family

ID=11407056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00981627T DK1233788T3 (da) 1999-11-18 2000-11-14 Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan

Country Status (19)

Country Link
US (2) US6780851B1 (de)
EP (1) EP1233788B1 (de)
AT (1) ATE239504T1 (de)
AU (1) AU782178C (de)
CA (1) CA2391625C (de)
CZ (1) CZ20021564A3 (de)
DE (1) DE60002607T2 (de)
DK (1) DK1233788T3 (de)
ES (1) ES2197890T3 (de)
HU (1) HU229365B1 (de)
IL (1) IL149619A0 (de)
IT (1) IT1307278B1 (de)
MX (1) MXPA02004987A (de)
NO (1) NO20022288L (de)
PL (1) PL204745B1 (de)
PT (1) PT1233788E (de)
SK (1) SK6982002A3 (de)
TN (1) TNSN00216A1 (de)
WO (1) WO2001035944A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
ITRM20010044A1 (it) * 2001-01-29 2002-07-29 Sigma Tau Healthscience Spa Integratore alimentare ad effetto dimagrante.
FR2900054B1 (fr) * 2006-04-21 2012-09-28 Kitozyme Sa Utilisation de polysaccharides d'origine fongique comme composition pharmaceutique ou complements alimentaires pour la sante humaine et animale
US7052722B2 (en) * 2003-12-01 2006-05-30 Cj Corp. Composition for weight reduction comprising water-soluble low-molecular weight chitosan and Hibiscus extract
MXPA05014089A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias inhibidoras de la recaptura de noradrenalina, dopamina y serotonina, combinadas con un aminoacido para el tratamiento de la obesidad y sobrepeso.
ITRM20060204A1 (it) 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
WO2013108263A1 (en) 2012-01-18 2013-07-25 Zota Health Care Ltd Pharmaceutical formulation to reduce inflammation of bones and joint friction with improved cartilage quality
CN105326053A (zh) * 2015-10-03 2016-02-17 王保红 含有左旋肉碱与壳寡糖的组合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
JP3108675B2 (ja) * 1998-03-17 2000-11-13 阪急共栄物産株式会社 脂質代謝改善剤
EP0951909B2 (de) * 1998-03-19 2010-10-20 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Kombinierte Zusammensetzung bestehend aus L-Karnitin oder L-Alkanoylkarnitin, einem Glycosaminoglycan und/oder einem seiner Bestandteile
AU747611B2 (en) * 1998-07-30 2002-05-16 E-Nutriceuticals, Inc. Novel chitosan-containing liquid compositions and methods for their preparation and use

Also Published As

Publication number Publication date
PL356183A1 (en) 2004-06-14
NO20022288D0 (no) 2002-05-14
HU229365B1 (hu) 2013-11-28
SK6982002A3 (en) 2002-09-10
AU782178B2 (en) 2005-07-07
PT1233788E (pt) 2003-09-30
US20050020538A1 (en) 2005-01-27
WO2001035944A2 (en) 2001-05-25
NO20022288L (no) 2002-05-14
IT1307278B1 (it) 2001-10-30
HUP0203379A2 (hu) 2003-02-28
WO2001035944A3 (en) 2002-02-07
CA2391625C (en) 2009-06-30
EP1233788A2 (de) 2002-08-28
US8198260B2 (en) 2012-06-12
ITRM990707A1 (it) 2001-05-18
ATE239504T1 (de) 2003-05-15
CA2391625A1 (en) 2001-05-25
AU782178C (en) 2006-08-10
US6780851B1 (en) 2004-08-24
HUP0203379A3 (en) 2003-12-29
TNSN00216A1 (fr) 2005-11-10
CZ20021564A3 (cs) 2002-11-13
ES2197890T3 (es) 2004-01-16
PL204745B1 (pl) 2010-02-26
AU1885101A (en) 2001-05-30
DE60002607T2 (de) 2004-03-18
EP1233788B1 (de) 2003-05-07
DE60002607D1 (de) 2003-06-12
ITRM990707A0 (it) 1999-11-18
MXPA02004987A (es) 2003-01-28
IL149619A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
CA2334875A1 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
PT1156814E (pt) Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
MXPA04004779A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
EP1863433A4 (de) Zusammensetzungen und verfahren zur erhöhung des stoffwechsels, der wärmeerzeugung und/oder der muskelbildung
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
EP1362846A4 (de) Aminoethanolderivate
TW200612903A (en) Use of trisubstituted benzopyranones
Liu et al. Evaluation of antihypertensive and antihyperlipidemic effects of bamboo shoot angiotensin converting enzyme inhibitory peptide in vivo
DK1233788T3 (da) Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
US20080081083A1 (en) Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome x
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
HK1118722A1 (en) Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
IS5416A (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
WO2000000183A3 (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HUP0203292A2 (hu) Alkanoil-L-karnitint és silybum marianum kivonatot tartalmazó máj- és epe-diszfunkciót megelőző gyógyélelmiszerek
HUP0104347A2 (hu) Propionil-L-karnitint és egy flavonoidot tartalmazó antioxidáns készítmény, amely a trombózis és az ateroszklerózis kezelésében alkalmazható
IT1291133B1 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato
TR200200015T2 (tr) L-Karnitin ve türevleri ile crataegus ekstreleri içeren kardiyoaktif bileşim
JP2004256522A (ja) 糖尿病予防・治療用組成物
BRPI0408409A (pt) composição de vacina contra o cólera